Dr. Anthony Mato, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Area of expertise
Chronic Lymphocytic Leukemia
Anthony Mato, MD has run 7 trials for Chronic Lymphocytic Leukemia. Some of their research focus areas include:
Cancer
Anthony Mato, MD has run 6 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Memorial Sloan Kettering Cancer Center
Cayuga Medical Center
Clinical Trials Anthony Mato, MD is currently running
Elacestrant
for Breast Cancer
The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.
Recruiting
2 awards
Phase 3
3 criteria
Biomarker Profiling
for Cancer
This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.
Recruiting
1 award
N/A
4 criteria
More about Anthony Mato, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 12 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Anthony Mato, MD has experience with
- Venetoclax
- Obinutuzumab
- Zanubrutinib
- Pirtobrutinib
- Rituximab
- Observation
Breakdown of trials Anthony Mato, MD has run
Chronic Lymphocytic Leukemia
Cancer
Lymphoma
CLL
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anthony Mato, MD specialize in?
Anthony Mato, MD focuses on Chronic Lymphocytic Leukemia and Cancer. In particular, much of their work with Chronic Lymphocytic Leukemia has involved TP53 positive patients, or patients who are Cys481 resistance mutation negative.
Is Anthony Mato, MD currently recruiting for clinical trials?
Yes, Anthony Mato, MD is currently recruiting for 5 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Anthony Mato, MD has studied deeply?
Yes, Anthony Mato, MD has studied treatments such as Venetoclax, Obinutuzumab, Zanubrutinib.
What is the best way to schedule an appointment with Anthony Mato, MD?
Apply for one of the trials that Anthony Mato, MD is conducting.
What is the office address of Anthony Mato, MD?
The office of Anthony Mato, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.